RHUMBLINE ADVISERS - CYTEK BIOSCIENCES INC ownership

CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 109 filers reported holding CYTEK BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CYTEK BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,777,379
-28.3%
321,992
+10.9%
0.00%
-33.3%
Q2 2023$2,480,203
+180541.2%
290,422
+94.4%
0.00%
+50.0%
Q1 2023$1,373
-5.7%
149,367
+4.8%
0.00%0.0%
Q4 2022$1,456
-99.9%
142,563
+1.3%
0.00%
-33.3%
Q3 2022$2,071,000
+49.6%
140,718
+9.1%
0.00%
+50.0%
Q2 2022$1,384,000
+33.3%
128,967
+34.0%
0.00%
+100.0%
Q1 2022$1,038,000
+328.9%
96,278
+549.5%
0.00%
Q4 2021$242,000
-4.0%
14,823
+26.0%
0.00%
Q3 2021$252,00011,7610.00%
Other shareholders
CYTEK BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,100,000$30,912,00012.48%
Miura Global Management 820,000$12,070,0007.24%
RA Capital Management 13,381,054$196,969,0004.20%
HHLR ADVISORS, LTD. 8,757,030$128,903,0003.39%
Brown Capital Management 4,406,461$64,863,0000.91%
Perceptive Advisors 1,289,534$18,982,0000.55%
Hillsdale Investment Management Inc. 344,529$5,072,0000.46%
PURA VIDA INVESTMENTS, LLC 527,164$7,760,0000.45%
Parkwood LLC 42,336$623,0000.09%
PDT Partners, LLC 31,436$463,0000.07%
View complete list of CYTEK BIOSCIENCES INC shareholders